Status:

RECRUITING

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Lead Sponsor:

University of Kansas Medical Center

Collaborating Sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)

FSHD Society

Conditions:

Facioscapulohumeral Muscular Dystrophy

Eligibility:

All Genders

18-75 years

Brief Summary

The primary cause of facioscapulohumeral muscular dystrophy (FSHD), a common adult-onset dystrophy, was recently discovered identifying targets for therapy. As multiple drug companies pursue treatment...

Detailed Description

The overall aim of this study is to hasten drug development for facioscapulohumeral muscular dystrophy (FSHD). Recent breakthroughs in FSHD research have identified the primary disease mechanism as th...

Eligibility Criteria

Inclusion

  • Patients with genetically confirmed FSHD1 or clinical diagnosis of FSHD with characteristic findings on exam and an affected parent or offspring
  • Patients with symptomatic limb weakness
  • Patients must be able to walk 30 feet without the support of another person or assistance (canes, walking sticks, and braces allowed; no walker).
  • If taking over the counter supplements, willing to remain consistent with supplement regimen throughout the course of the study

Exclusion

  • Patients with cardiac or respiratory dysfunction (deemed clinically unstable, or would interfere with safe testing, in the opinion of the Investigator)
  • Patients with orthopedic conditions that preclude safe testing of muscle function
  • Patients that regularly use available muscle anabolic/catabolic agents such as corticosteroids, oral testosterone or derivatives, or oral beta agonists
  • Patients that have used an experimental drug in an FSHD clinical trial within the past 30 days
  • Patients that are pregnant

Key Trial Info

Start Date :

March 5 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

320 Patients enrolled

Trial Details

Trial ID

NCT03458832

Start Date

March 5 2018

End Date

December 1 2027

Last Update

April 23 2025

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

University of California Los Angeles

Los Angeles, California, United States, 90095

2

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

3

Kennedy Krieger Institute

Baltimore, Maryland, United States, 21205

4

University of Rochester Medical Center

Rochester, New York, United States, 14642